# Paul-Ehrlich-Gesellschaft für Chemotherapie

> organisation involved in scholarly research

**Wikidata**: [Q74557738](https://www.wikidata.org/wiki/Q74557738)  
**Source**: https://4ort.xyz/entity/paul-ehrlich-gesellschaft-fur-chemotherapie

## Summary
The Paul-Ehrlich-Gesellschaft für Chemotherapie is a German nonprofit research institute focused on advancing chemotherapy and scholarly research, named after Nobel laureate Paul Ehrlich. Headquartered in Rheinbach, it operates as a registered association, contributing to medical science with a specialization in infectious diseases.

## Key Facts
- **Headquarters**: Rheinbach, Germany, at von-Liebig-Straße 20, 53359 Rheinbach.
- **Legal Form**: Registered association (eingetragener Verein) in Germany.
- **Founded**: Legal entity identifier activated on January 16, 2018.
- **Focus**: Research in chemotherapy and infectious diseases, affiliated with the journal *GMS Infectious Diseases*.
- **Nonprofit Status**: Certified nonprofit organization.
- **Identifiers**: VIAF ID 147804423, Legal Entity Identifier 529900ZPCIHOPPUCN209.

## FAQs
### Q: What is the primary focus of the Paul-Ehrlich-Gesellschaft für Chemotherapie?
A: The organization specializes in scholarly research related to chemotherapy and infectious diseases.

### Q: Where is the organization based?
A: It is headquartered in Rheinbach, Germany, at von-Liebig-Straße 20.

### Q: Is the organization a nonprofit?
A: Yes, it is formally registered as a nonprofit organization in Germany.

## Why It Matters
The Paul-Ehrlich-Gesellschaft für Chemotherapie plays a critical role in advancing medical research, particularly in chemotherapy and infectious diseases. As a nonprofit entity, it prioritizes scholarly collaboration over commercial interests, fostering innovation in treatment development. Its affiliation with reputable journals like *GMS Infectious Diseases* underscores its credibility and impact in the scientific community. By concentrating on specialized research, the organization addresses global health challenges, contributing to improved therapies and diagnostic methods. This work aligns with the legacy of Paul Ehrlich, a pioneer in immunology and chemotherapy, ensuring continued progress in his field of study.

## Notable For
- **Specialization**: Unique focus on chemotherapy research within Germany.
- **Nonprofit Model**: Operates independently as a registered association, ensuring unbiased scientific pursuit.
- **Academic Affiliation**: Linked to the peer-reviewed journal *GMS Infectious Diseases*, enhancing research dissemination.
- **Legacy Connection**: Named after Paul Ehrlich, a foundational figure in microbiology and Nobel laureate.

## Body
### Organization Type
The Paul-Ehrlich-Gesellschaft für Chemotherapie is classified as both a **research institute** and a **nonprofit organization**. It is legally structured as a registered association (eingetragener Verein) in Germany, emphasizing its commitment to public benefit over profit.

### Headquarters and Legal Structure
- **Location**: Rheinbach, Germany (postal code 53359), with the full address von-Liebig-Straße 20.
- **Legal Status**: Registered under the Legal Entity Identifier (LEI) 529900ZPCIHOPPUCN209, activated on January 16, 2018.

### Research Focus
The institute’s work is closely tied to the journal *GMS Infectious Diseases*, reflecting its emphasis on:
- Chemotherapy research.
- Infectious disease studies.
- Scholarly collaboration and publication.

### Identifiers and Classifications
- **VIAF ID**: 147804423 (verified as of June 20, 2023).
- **National Library of Israel ID**: 987007601475505171.
- **NLCR AUT ID**: nlk20050162863 (associated with the name "Paul-Ehrlich-Gesellschaft").
- **Yale LUX ID**: group/9b05d99d-5192-463a-8f0f-f2d24e28a5f1.

## References

1. [Directory of Open Access Journals](http://www.egms.de/en/journals/id/about.htm#review)
2. Virtual International Authority File
3. National Library of Israel Names and Subjects Authority File